Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 2 Aug 2006 |
| InvestorService: Genmab, Named Finalist for European Biotechnica Award 2006 | 2 Aug 2006 |
| Genmab, Capital Increase in Genmab as a Result of Employee Warrant Exercise | 28 Jul 2006 |
| Genmab, Initiates Ofatumumab (HuMax-CD20) Pivotal Study in NHL | 10 Jul 2006 |
| Genmab, articles of association dated June 21, 2006 | 6 Jul 2006 |